Andrew Wang

Conference European Heart Journal · November 5, 2025 AbstractBackgroundPivotal clinical trials evaluating symptomatic patients with oHCM demonstrated significant improvements in sy ... Full text Cite

Abstract 4359841: Patient-Reported Outcomes in Patients with Symptomatic, Obstructive Hypertrophic Cardiomyopathy Treated with Mavacamten: Real-world Observations through Week 30 from the COMPASS-HCM Study

Conference Circulation · November 4, 2025 Background: Clinical trials have demonstrated mavacamten’s efficacy in improving health status of patients with obstructive hypertrophic cardiomyopathy (oHCM), but real-world data rema ... Full text Cite

Aspirin Versus Clopidogrel Following Transcatheter Aortic Valve Replacement: A TVT Registry Propensity Matched Analysis

Conference JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · October 28, 2025 Link to item Cite

Machine Learning Computer Vision Point of Care Decision Support of Echocardiographic Identification of Hypertrophic Cardiomyopathy.

Conference JACC Adv · May 2025 BACKGROUND: Hypertrophic cardiomyopathy (HCM) remains underdiagnosed, and artificial intelligence tools for echocardiographic recognition have been hampered by lack of insight into drivers of model predictions and ease of implementation. OBJECTIVES: The pu ... Full text Link to item Cite

SMARTWATCH ALERTS LEADING TO DIAGNOSIS OF GENETIC DILATED CARDIOMYOPATHY

Conference JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · April 1, 2025 Link to item Cite

BEDSIDE RISK PREDICTION OF ADVERSE OUTCOMES IN MEDICALLY TREATED PATIENTS WITH SEVERE TRICUSPID REGURGITATION

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 7, 2023 Link to item Cite

ANTIBIOTIC PROPHYLAXIS ADHERENCE AFTER VALVE REPLACEMENT SURGERY

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 7, 2023 Link to item Cite

THE EFFECT OF MAVACAMTEN TREATMENT FOR SYMPTOMATIC, OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS WITH OR WITHOUT HYPERTENSION: ANALYSIS OF THE EXPLORER-HCM TRIAL

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 7, 2023 Link to item Cite

THE EFFECT OF MAVACAMTEN TREATMENT FOR SYMPTOMATIC, OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS OF OLDER AGE AND LONGER DURATION OF DIAGNOSIS: ANALYSIS OF THE EXPLORER-HCM TRIAL

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 7, 2023 Link to item Cite

Utilization of Primary Prevention Implantable Cardioverter Defibrillator (ICD) Among Older Patients With Hypertrophic Cardiomyopathy (HCM): A Real World Analysis

Conference CIRCULATION · November 8, 2022 Link to item Cite

Clinical Outcomes Following Primary Prevention Implantable Cardioverter Defibrillator (ICD) Implantation Among Older Patients With Hypertrophic Cardiomyopathy (HCM)

Conference CIRCULATION · November 8, 2022 Link to item Cite

Clinical outcomes among distinct groups of patients with severe tricuspid valve regurgitation

Conference EUROPEAN HEART JOURNAL · October 2022 Link to item Cite

Long-term safety and effectiveness of mavacamten in symptomatic obstructive hypertrophic cardiomyopathy (oHCM) patients (pts): update from PIONEER open-label extension (PIONEER-OLE) study

Conference EUROPEAN HEART JOURNAL · October 1, 2019 Link to item Cite

The association between vegetation size and surgical treatment on 6-month mortality in left-sided infective endocarditis.

Conference Eur Heart J · July 14, 2019 AIMS: In left-sided infective endocarditis (IE), a large vegetation >10 mm is associated with higher mortality, yet it is unknown whether surgery during the acute phase opposed to medical therapy is associated with improved survival. We assessed the associ ... Full text Link to item Cite

PRE- VERSUS POST-PROCEDURE CLINICAL EVENT RATES AND ASSOCIATED HEALTHCARE RESOURCE UTILIZATION IN PATIENTS UNDERGOING COMMERCIAL MITRACLIP PLACEMENT

Conference Journal of the American College of Cardiology · March 2019 Full text Cite

EXPLORER-HCM: Phase 3 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Conference CIRCULATION · November 6, 2018 Link to item Cite

MAVERICK-HCM: Phase 2 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Concentration-Guided Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Conference CIRCULATION · November 6, 2018 Link to item Cite

Mavacamten Improves Left Ventricular Relaxation and Compliance in Obstructive Hypertrophic Cardiomyopathy Through Direct Myosin Modulation

Conference CIRCULATION · November 6, 2018 Link to item Cite

ECHOCARDIOGRAPHIC PREDICTORS FOR IN-HOSPITAL AND 1-YEAR OUTCOMES IN LEFT-SIDED INFECTIVE ENDOCARDITIS: AN ANALYSIS FROM THE INTERNATIONAL COLLABORATION ON ENDOCARDITIS-PROSPECTIVE ECHO COHORT STUDY

Conference Journal of the American College of Cardiology · March 2017 Full text Cite

The Association Between Post-Operative Pulmonary Hypertension and Survival After Mitral Valve Surgery

Conference CIRCULATION · November 11, 2016 Link to item Cite

The Association Between Post-Operative Pulmonary Hypertension and Survival After Mitral Valve Surgery

Conference CIRCULATION · November 11, 2016 Link to item Cite

The EVEREST II REALISM Continued Access Study-1 year outcomes in patients with functional mitral regurgitation reported by baseline New York Heart Association functional class

Conference EUROPEAN HEART JOURNAL · August 1, 2016 Link to item Cite

CLINICAL AND ECHOCARDIOGRAPHIC PREDICTORS OF EXERCISE CAPACITY FOLLOWING MITRAL VALVE SURGERY FOR MITRAL REGURGITATION

Conference Journal of the American College of Cardiology · April 2016 Full text Cite

The EVEREST II REALISM Continued Access study-1 year outcomes in patients with primary mitral regurgitation

Conference EUROPEAN HEART JOURNAL · August 1, 2015 Link to item Cite

TCT-85 Ventricular and Atrial Remodeling after the Percutaneous MitraClip: 4 year Follow-up Data from the EVEREST II Randomized Controlled Trial

Conference Journal of the American College of Cardiology · October 2013 Full text Cite

Association between type of valve prosthesis and one year mortality in IE: an analysis of 1467 patients from the International collaboration on endocarditis prospective cohort study

Conference EUROPEAN HEART JOURNAL · August 1, 2013 Link to item Cite

SY.3.1 CLINICAL CHARACTERISTICS AND OUTCOME OF INFECTIVE ENDOCARDITIS INVOLVING IMPLANTABLE CARDIAC DEVICES

Conference International Journal of Antimicrobial Agents · May 2013 Full text Cite

THE IMPACT OF VALVE SURGERY ON MORTALITY IN INFECTIVE ENDOCARDITIS COMPLICATED WITH EMBOLIC STROKE: A PROPENSITY SCORE ANALYSIS

Conference INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS · May 1, 2013 Link to item Cite

Access to Care: Geographical Variations in the Diagnosis and Treatment of Aortic Stenosis in North Carolina

Conference CIRCULATION · November 20, 2012 Link to item Cite

EVEREST II Randomized Clinical Trial: A Critical Assessment of the Safely Data in Patients treated with the MitraClip

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · September 21, 2010 Link to item Cite

Alcohol Septal Ablation is Not Associated With an Increase in Sudden or All-cause Mortality in Obstructive Hypertrophic Cardiomyopathy: A Meta-analysis

Conference CIRCULATION · November 3, 2009 Link to item Cite

Kansas City Cardiomyopathy Questionnaire Scores Correlate With NYHA Classification and Exercise Parameters in Patients With Hypertrophic Cardiomyopathy

Conference CIRCULATION · November 3, 2009 Link to item Cite

Significant reverse remodeling of the left ventricle one year after percutaneous mitral repair with the MitraClip (TM) device

Conference AMERICAN JOURNAL OF CARDIOLOGY · October 20, 2007 Link to item Cite

Echocardiography provides important prognostic information in patients with advanced pulmonary hypertension, even after initiation of vasodilator therapy

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 6, 2007 Link to item Cite

Regional variation in the presentation and outcome of patients with infective endocarditis (IE): The international collaboration on endocarditis-prospective cohort study

Conference CIRCULATION · October 31, 2006 Link to item Cite

The significance of health care-associated infection in prosthetic valve infective endocarditis

Conference CIRCULATION · October 31, 2006 Link to item Cite

Regional differences in the clinical characteristics, complications and treatment of prosthetic valve infective endocarditis: A global perspective from the international collaboration on endocarditis prospective cohort study

Conference CIRCULATION · October 31, 2006 Link to item Cite

The use of early surgery in definite infective endocarditis (IE): A propensity matched analysis from 1622 patients

Conference CIRCULATION · October 31, 2006 Link to item Cite

Pulmonary hypertension with excessive transpulmonary gradients among mitral stenotics: Prevalence and clinical outcome following percutaneous balloon mitral commissurotomy

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · February 21, 2006 Link to item Cite

Echocardiographic risk-stratification for early surgery in patients with endocarditis is a cost-attractive alternative to standard care

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · February 21, 2006 Link to item Cite

The influence of myocardial fibrosis by delayed enhanced MRI on left ventricular diastolic function in hypertrophic cardiomyopathy

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · February 21, 2006 Link to item Cite

An unusual case of hypoxia diagnosed by cardiac magnetic resonance imaging

Conference CIRCULATION · October 25, 2005 Link to item Cite

The use and effect of surgical therapy for prosthetic valve infective endocarditis: A propensity analysis of a multicenter, international cohort

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · February 1, 2005 Link to item Cite

What definition of vasoreactivity to inhaled nitric oxide best predicts mortality risk in patients with pulmonary hypertension?

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · February 1, 2005 Link to item Cite

1123-185 Is there regional variation in levels of serum brain natriuretic peptide in patients with pulmonary hypertension?

Conference Journal of the American College of Cardiology · March 2004 Full text Cite

1143-136 Prosthetic valve endocarditis: Report of 214 cases from the intracardiac echocardiography prospective cohort study

Conference Journal of the American College of Cardiology · March 2004 Full text Cite

868-2 Cardiovascular risk factors and outcomes in patients with definite endocarditis: The international collaboration on endocarditis - prospective cohort study

Conference Journal of the American College of Cardiology · March 2004 Full text Cite

1143-135 The risk of prosthetic valve endocarditis in patients with staphylococcus aureus bacteremia

Conference Journal of the American College of Cardiology · March 2004 Full text Cite

Serum brain natriuretic peptide levels cannot differentiate pulmonary disease from left-heart failure if the right ventricle is dilated

Conference CIRCULATION · October 28, 2003 Link to item Cite

Vasodilator response to inhaled nitric oxide is the most powerful predictor of survival in patients with pulmonary hypertension

Conference CIRCULATION · October 28, 2003 Link to item Cite

Cardiovascular risk factors and outcomes in patients with definite endocarditis: Findings from 1024 patients in the ICE prospective cohort study

Conference CIRCULATION · October 28, 2003 Link to item Cite

Differences between patients with prosthetic valve and native valve endocarditis: Report from the Duke endocarditis service

Conference CIRCULATION · October 23, 2001 Link to item Cite